Ninety‐one patients with disseminated testicular non‐seminomas were treated with 3 to 4 cycles of cisplatin, vinblastine, and bleomycin (PVB) induction chemotherapy followed by cisplatin and vinblastine maintenance therapy for 1 year. The follow‐up of these patients ranges from 24 to 66 months. Forty‐nine (54%) patients achieved complete remission by chemotherapy alone and 14 (15%) were rendered free of tumor by surgery after chemotherapy, for a total complete remission rate of 69%. Three complete responders relapsed within 13 months, and two died. One additional complete responder died of a non‐cancer‐related cause. One of the surgical complete responders relapsed and died. Overall, 58 (64%) patients remain free of disease. The 5‐year survival is 95% for complete responders, 32% for partial responders, and 72% overall. This combination regimen has significantly improved the survival of disseminated testicular cancer patients, equaling that of Stage II patients in older literature.
|Original language||English (US)|
|Number of pages||4|
|State||Published - 1984|
ASJC Scopus subject areas
- Cancer Research